Nakatsukasa, Hitomi
Takahashi, Masaya
Shibano, Masahito
Ishigami, Yusuke
Kawaguchi, Tomoya
Nakamura, Yasutaka
Kaneda, Hiroyasu https://orcid.org/0000-0002-7696-2391
Article History
Received: 30 April 2024
Accepted: 1 September 2024
First Online: 15 September 2024
Declarations
:
: Dr. Kaneda has received lecture fees Chugai, MSD, Ono pharmaceutical, and Bristol-Myers Squibb. All other authors declare that they have no conflicts of interest.
: This study was approved by the Human Subjects Review Committee of Osaka Metropolitan University (approval no. 2023–003).
: Informed consent was obtained from patients using an opt-out form based on the Ethical Guidelines for Medical and Biological Research Involving Human Subjects by the Japanese Ministry of Health, Labour and Welfare to provide a chance to decline participation.
: Not applicable.